Drug delivery platforms
BioNxt develops ways to deliver medicines in easier-to-take formats such as oral thin films, tablets, and other non-invasive dosage forms.
Customers and revenue model
B
BioNxt Solutions Inc
F:BXT
BioNxt Solutions Inc
F:BXT
Price:
0.1665
EUR
-3.48%
Market Closed
Market Cap:
€18.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Headquarters
- Canada CA
- IPO date
- Aug 6, 2019
BioNxt Solutions Inc. is a life sciences company focused on drug delivery technology. It develops ways to reformulate existing medicines into easier-to-use products such as oral dissolving films, tablets, skin patches, and similar dosage forms. The idea is to make drugs simpler to take, improve how they are absorbed, and support better patient compliance.
The company works mainly with pharmaceutical and healthcare partners, and its customers can include drug developers, licensees, and eventually patients through partnered products. BioNxt can make money by licensing its delivery technologies, entering development and commercialization partnerships, and potentially earning royalties or other payments if its formulations are taken to market.
What sets BioNxt apart is that it sits in the drug reformulation layer rather than trying to discover new medicines from scratch. Instead of building entirely new active ingredients, it focuses on turning known drugs into more convenient or effective delivery formats, which can be attractive for companies looking to extend a product's life, improve usability, or open new treatment options.
Continue BXT Research
Other BioNxt Solutions Inc listings: